Catalyst
Slingshot members are tracking this event:
Amgen And UCB Submit Biologics License Application For Romosozumab To The FDA
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| AMGN |
|
|
||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Jul 22, 2016
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Phase 3 Frame Study, Postmenopausal Women With Osteoporosis, Romosozumab, Sclerostin, Protein, Bone Resorption, Inhibiting Sclerostin, Monoclonal Antibody, Frame
